Eyenovia Announces Conference Call and Webcast for Second Quarter 2020 Financial Results
July 29 2020 - 8:30AM
Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic
biopharmaceutical company developing a pipeline of microdose array
print (MAP™) therapeutics, today announced that the Company will
release financial results for the second quarter ended June 30,
2020 on Wednesday, August 12, 2020, after the market closes.
Following the release, Dr. Sean Ianchulev, Chief Executive Officer
and Chief Medical Officer, John Gandolfo, Chief Financial Officer,
and Michael Rowe, Vice President, Commercial will host a conference
call to review the financial results.
The conference call is scheduled to begin at 4:30pm
ET on Wednesday, August 12, 2020. Participants should dial
1-866-916-2921 (United States) or 1-210-874-7771 (International)
with the conference code 7380187. A live webcast of the conference
call will also be available on the investor relations page of the
Company's corporate website at www.eyenovia.com.
After the live webcast, the event will be archived
on Eyenovia’s website for one year. In addition, a telephonic
replay of the call will be available until August 19, 2020. The
replay can be accessed by dialing 1-855-859-2056 (United States) or
1-404-537-3406 (International) with confirmation code 7380187.
About EyenoviaEyenovia, Inc.
(NASDAQ: EYEN) is a clinical stage ophthalmic biopharmaceutical
company developing a pipeline of microdose array print (MAPTM)
therapeutics. Eyenovia’s pipeline is currently focused on the
late-stage development of microdosed medications for presbyopia,
myopia progression and mydriasis. For more Information, please
visit www.eyenovia.com.
Company Contact:Eyenovia, Inc.John
GandolfoChief Financial Officerjgandolfo@eyenoviabio.com
Investor Contact:The Ruth
GroupAlexander LoboPhone: 646-536-7037alobo@theruthgroup.com
Eyenovia (NASDAQ:EYEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eyenovia (NASDAQ:EYEN)
Historical Stock Chart
From Apr 2023 to Apr 2024